METHOD AND SYSTEM FOR TREATING CARDIOVASCULAR DISEASE
A system and method for treating congestive heart failure in a patient, including: implanting at least one pressure sensor in a desired location within the patient; providing an ex-vivo interrogation system and monitoring system that can be configured to optionally affect at least one of: selectively energizing the at one pressure sensor, receiving a return or output signal from the at one pressure sensor, processing the return signal, and displaying processed data derived from the at least one pressure sensor to a physician. The system and method also includes deriving diagnostic and treatment information from the processed data and sending diagnostic and treatment information to the patient.
1 . A method for treating congestive heart failure in a patient, comprising:
implanting at least one pressure sensor in a desired location within the patient;
providing an ex-vivo interrogation system and monitoring system that can be configured to optionally affect at least one of: selectively energizing the at one pressure sensor, receiving a return or output signal from the at one pressure sensor, processing the return signal, and displaying processed data derived from the at least one pressure sensor to a physician, wherein the processed data comprises at least one of a sensor serial number, a date/time of when reading was taken, a patient identifier, determined systolic, diastolic and mean pressures, average frequency of reading, average and minimum signal strength of reading, point by point pressure waveform samples, cardiac output, heart rate, point by point signal strength waveform, interrogation system serial number, implant calibration intercept of pressure, implant calibration area of cardiac output, version of software on the interrogation system, sensor slope 1 and slope 2, atmospheric pressure, and sensor type.
2 . The method of claim 1 , further comprising deriving diagnostic and treatment information from the processed data.
3 . The method of claim 2 , further comprising sending diagnostic and treatment information to the patient.
4 . The method of claim 3 , further comprising allowing the patient to continue or modify prescribed medications to achieve optimal therapeutic doses generally without direct intervention of the physician.
5 . A system for treating congestive heart failure in a patient, comprising:
at least one pressure sensor comprising a resonant circuit that is operable to generate a sensor signal that is indicative of a pressure when positioned in a desired location within a patient and energized;
an ex-vivo interrogation system comprising a base unit having a receiver, wherein the base unit is operably connected to a coupling loop operable to selectively energize the at least one pressure sensor and couple the sensor signal of the sensor into the receiver, wherein the interrogation system is operable to communicate the sensor signal to a location outside of the patient;
an ex-vivo monitoring system comprising at least one processor operatively coupled to the ex-vivo interrogation system, wherein the monitoring system is programmed to convert the sensor signal to a pressure signal and determine and output at least one type of processed data based on the at least one pressure sensor, the ex-vivo monitoring system and the determined pressure signal.
6 . The system of claim 5 , wherein the interrogation system further comprises a user interface.
7 . The system of claim 6 , wherein the user interface comprises a display device.
8 . The system of claim 6 , wherein the user interface comprises an input device.
9 . The system of claim 5 , wherein the coupling loop further comprises a transmit loop and a receive loop.
10 . The system of claim 5 , wherein the monitoring system and the interrogation system are at least partially coextant.
11 . The system of claim 5 , wherein the at least one pressure sensor further comprises a monolithic housing.
12 . The system of claim 5 , wherein the sensor signal comprises a resonant frequency of the resonant circuit.
13 . The system of claim 5 , wherein the pressure sensor and the interrogation system are co-located.
14 . The system of claim 13 , wherein the monitoring system is remote from the sensor and interrogation system.
15 . The system of claim 13 , wherein the monitoring system is co-located with the sensor and interrogation system.
16 . The system of claim 5 , wherein processed data is selected from the group comprising: comprises at least one of a sensor serial number, a date/time of when reading was taken, a patient identifier, determined systolic, diastolic and mean pressures, average frequency of reading, average and minimum signal strength of reading, point by point pressure waveform samples, cardiac output, heart rate, point by point signal strength waveform, interrogation system serial number, implant calibration intercept of pressure, implant calibration area of cardiac output, version of software on the interrogation system, sensor slope 1 and slope 2, atmospheric pressure, and sensor type.